Business Trends– category –
-
Business Trends
ProBio and Curocell Achieve BLA Approval for Next-Gen CD19-Targeted CAR-T Therapy, Initiating Commercial Production in South Korea
ProBio CDMO South Korea Overview ProBio CDMO and Curocell have secured Biologics License Application (BLA) approval for anbalcabtagene autoleucel (Anbal-cel; CRC01), their next-generation CD19-targeted CAR-T cell therapy for relapsed or ... -
Business Trends
Terumo BCT and Steminent Partner to Automate Mesenchymal Stem Cell Manufacturing for Late-Stage Clinical Commercialization
Terumo Blood and Cell Technologies Taiwan Overview Terumo Blood and Cell Technologies (Terumo BCT) and Taipei-based Steminent Biotherapeutics Inc. have announced a strategic collaboration to accelerate late-stage manufacturing readiness ... -
Business Trends
Helios Advances ARDS Therapy Approval, Bolstering Regenerative Medicine CDMO with New Kobe Manufacturing Hub
FISCO Japan Overview Helios is progressing towards regulatory approval for its Acute Respiratory Distress Syndrome (ARDS) therapeutic, HLCM051, while simultaneously enhancing its Contract Development and Manufacturing Organization (CDMO)... -
Business Trends
Aldevron and Minaris Renew Lentiviral Plasmid Agreement, Bolstering Critical Supply for Advanced Cell and Gene Therapies
BioBuzz USA Overview Aldevron and Minaris have renewed their lentiviral plasmid licensing agreement, significantly expanding access to scalable plasmid solutions essential for advanced cell and gene therapy (CGT) developers. This collabo... -
Business Trends
Meatly Secures $14M Series A to Build Europe’s Largest Cultivated Meat Facility in London
Green Queen Media UK Overview British food tech firm Meatly has raised £10 million ($14.1 million) in Series A funding to construct a 20,000-liter cultivated meat pilot plant in London, set to become Europe's largest. The company, which ... -
Business Trends
FDA Finalizes Guidance on CMC Flexibility for Cell and Gene Therapies, Expediting Access to Advanced Treatments
Regulatory Focus USA Overview The U.S. FDA has issued final guidance outlining flexible Chemistry, Manufacturing, and Controls (CMC) requirements for cell and gene therapy (CGT) products, recognizing their inherent complexities compared ... -
Business Trends
Aternium Selects Siemens Energy for FEED of Mid-Atlantic Clean Hydrogen Project Integrating Heavy Water Extraction
Modern Power Systems USA Overview Aternium has chosen Siemens Energy to lead the Front-End Engineering Design (FEED) for its planned Mid-Atlantic clean hydrogen production facility. This unique project aims not only to supply clean hydro... -
Business Trends
Nel ASA Unveils Next-Generation Pressurized Alkaline Electrolyzer, Targeting Sub-$1,450/kW for Green Hydrogen Production
PV Magazine Europe (Norway) Overview Nel ASA has commercially launched its next-generation pressurized alkaline electrolyzer platform, engineered to drastically reduce green hydrogen production costs and improve efficiency. The system ta... -
Business Trends
U.S. Department of Energy Announces Multi-Billion Dollar Funding to Accelerate Long-Duration Energy Storage Commercialization
米国エネルギー省 (DOE) USA Overview The U.S. Department of Energy (DOE) has unveiled a new multi-billion dollar funding program designed to fast-track the commercialization of Long-Duration Energy Storage (LDES) technologies. This substa... -
Business Trends
Panasonic and Tesla Deepen Collaboration on Revolutionary Dry Electrode Manufacturing for EV Batteries
Panasonic Energy Japan Overview Panasonic Energy and Tesla are intensifying their collaboration on dry electrode manufacturing technology, aiming to significantly reduce the environmental impact and cost of EV battery production. This in...